NCI Funds 24 DNA Microarray Laboratories Nationwide

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 8 No 11
Volume 8
Issue 11

BETHESDA, Md-Twenty-four cancer research centers in the United States will receive a total of $4.1 million from the National Cancer Institute to purchase the necessary equipment to establish DNA microarray facilities. The new and technically challenging research tool enables scientists to assess expression levels of a large subset of the human genes in a cell or tissue.

BETHESDA, Md—Twenty-four cancer research centers in the United States will receive a total of $4.1 million from the National Cancer Institute to purchase the necessary equipment to establish DNA microarray facilities. The new and technically challenging research tool enables scientists to assess expression levels of a large subset of the human genes in a cell or tissue.

The NCI intends for the DNA microarray laboratories to provide technical support to cancer researchers and to make the technology widely available so that it is rapidly applied to investigating a broad range of critical problems in cancer research.

Recent Videos
Sonia Jain, PhD, stated that depatuxizumab mafodotin, ABBV-221, and ABBV-321 were 3 of the most prominent ADCs in EGFR-amplified glioblastoma.
2 experts are featured in this series.
2 experts are featured in this series.
Skin toxicities are common with targeted therapies for GI malignancies but can be remedied by preventative measures and a collaboration with dermatology.
Computational models help researchers anticipate how ADCs may behave in later lines of development, while they are still in the early stages.
2 experts are featured in this series.
ADC payloads with high levels of potency can sometimes lead to higher levels of toxicity, which can eliminate the therapeutic window for patients with cancer.
According to Greg Thurber, PhD, target-mediated uptake is the biggest driver of efficacy for antibody-drug conjugates as a cancer treatment.
Two experts are featured in this series.
Related Content